Halcyon Labs

Mumbai, India Founded: 1989 • Age: 37 yrs
Develops and manufactures high-quality pharmaceutical products for global export.

About Halcyon Labs

Halcyon Labs is a Healthcare company based in Mumbai (India) founded in 1989. It develops and manufactures high-quality pharmaceutical products for global export. It operates on a B2B model. Halcyon Labs has raised $475.06 thousand across 1 funding round. The company has 80 employees. Its Indian entity Halcyon Labs Private Limited reported revenue of β‚Ή52.86 Cr. Halcyon Labs offers products and services including APIs, API Intermediates, and Product Under Development. Its focus areas include Pharmaceuticals, APIs, Steroids and Anti-Fungal Products. Its competitors include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed competitors have raised funding.

Company details

Halcyon Labs specializes in creating innovative steroids and anti-fungal products through advanced RD and manufacturing processes. They maintain rigorous quality standards and international certifications to ensure reliable results. Based in Mumbai and Ahmedabad, India, the company exports to over 50 countries and serves more than 125 clients worldwide, focusing on health and wellness solutions.

  • Headquarters Mumbai, India
  • Employees 80
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website halcyonlabs.com
  • Social LinkedIn
  • Legal Name Halcyon Labs Private Limited
  • Date of Incorporation 29 May, 1984
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹52.86 Cr

    FY 2024 · -4% YoY

  • Net Profit
    ₹3.46 Cr

    FY 2024 · 7% margin

  • EBITDA
    ₹5.60 Cr

    FY 2024 · 11% margin

  • Total Equity Funding
    $475.06K (USD)

    in 1 rounds

  • Latest Funding Round
    $475.06K (USD), Seed

    Mar 2015

  • Employee Count
    80

Products & Services of Halcyon Labs

Halcyon Labs offers a comprehensive portfolio of products and services, including APIs, API Intermediates, and Product Under Development.

APIs
Pharmaceutical Products

Active ingredients for steroids and health solutions.

API Intermediates
Chemical Intermediates

Raw materials for API production in pharmaceuticals.

Product Under Development
New Innovations

Upcoming pharmaceutical items for health applications.

Funding Insights of Halcyon Labs

Halcyon Labs has successfully raised a total of $475.06K through 1 strategic funding round. The most recent funding activity was a Seed round of $475.06 thousand completed in March 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $475,063
  • Total Rounds 1
  • Last Round Seed β€” $475,063
  • First Round $475,063

    (Mar 2015)

All 1 funding rounds of Halcyon Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2015$475,063Seed––
–

Board of directors of Halcyon Labs Private Limited (Halcyon Labs)

Halcyon Labs Private Limited is the primary company behind Halcyon Labs. The board of Halcyon Labs Private Limited currently have 4 directors; the longest-serving is Rupa Sudhir Merchant, appointed in 1989. 11 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Rupa Sudhir Merchant
DIN 00092488
Director11 Sep 198937 yrs 1 moHalcyon Labs Private Limited
Aditya Sudhir Merchant
DIN 02725972
Managing Director01 Aug 200917 yrs 2 moHalcyon Labs Private Limited
Nandini Sudhir Merchant
DIN 07566968
Director19 Jul 201610 yrs 3 moHalcyon Labs Private Limited
Amrita Aditya Merchant
DIN 08662539
Director10 Jan 20206 yrs 9 moHalcyon Labs Private Limited

Financials of Halcyon Labs

Figures of Halcyon Labs Private Limited, the primary company behind Halcyon Labs, for FY 2024. Revenue was ₹52.86 Cr (-4% year on year). Net profit was ₹3.46 Cr (7% margin). EBITDA was ₹5.60 Cr (11% margin). Revenue has grown at a compounded annual rate of -1% over three years and +2% over five years.

  • ₹52.86 CrRevenue · FY 2024 · -4% YoY
  • ₹3.46 CrNet profit · 7% margin
  • ₹5.60 CrEBITDA · 11% margin
  • ₹65.7 LakhPaid-up capital
  • 80Employees (provident fund records)
  • -1%Revenue CAGR, 3 years
  • +2%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Halcyon Labs Private Limited are on its company page.

Premium access

Detailed financial statements for Halcyon Labs

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Halcyon Labs

2 dated milestones of Halcyon Labs across 26 years, from founding to its latest funding, stage changes and deals.

  1. Founded Halcyon Labs is founded.
  2. Funding First funding round of $475K.

Competitors of Halcyon Labs

Halcyon Labs has 3 listed competitors in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lauruslabs.com2005Hyderabad, India$229.73M6,035
Pharmaceutical and biotechnology company
symbiotec.in2002Indore, India$61.01M1,822
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
sequent.in2002Bengaluru, India
APIs are developed and manufactured for therapeutic areas.
Premium access

Detailed competitors of Halcyon Labs

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Halcyon Labs

Halcyon Labs was founded in 1989 and raised its 1st funding round 26 years after it was founded.

Halcyon Labs is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Halcyon Labs is a funded company, having raised a total of $475.06K across 1 funding round to date. The company's 1st funding round was a Seed of $475.06K, raised on Mar 2015.

Halcyon Labs has 80 employees.

The primary company behind Halcyon Labs, Halcyon Labs Private Limited, reported revenue of β‚Ή52.86 Cr for FY 2024, down 4% year on year.

Halcyon Labs specializes in creating innovative steroids and anti-fungal products through advanced RD and manufacturing processes. They maintain rigorous quality standards and international certifications to ensure reliable results. Based in Mumbai and Ahmedabad, India, the company exports to over 50 countries and serves more than 125 clients worldwide, focusing on health and wellness solutions.

Halcyon Labs's top competitors include Laurus Labs, Symbiotec and SeQuent.

Halcyon Labs offers APIs, API Intermediates, and Product Under Development.

Halcyon Labs operates through Halcyon Labs Private Limited.

The legal entities of Halcyon Labs currently have 4 directors, including Amrita Aditya Merchant, Nandini Sudhir Merchant, Rupa Sudhir Merchant and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available